CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs - ScienceDirect
Por um escritor misterioso
Descrição
CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model - ScienceDirect
Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia
PDF) CRISPR/Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in Dominant Optic Atrophy patient-derived iPSCs
Dead Cas(t) light on new life: CRISPRa-mediated reprogramming of somatic cells into neurons
IJMS, Free Full-Text
PDF) CRISPR/Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in Dominant Optic Atrophy patient-derived iPSCs
Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity
OPA1 regulation of mitochondrial dynamics in skeletal and cardiac muscle: Trends in Endocrinology & Metabolism
In vivo modeling of human neuron dynamics and Down syndrome
CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs: Molecular Therapy - Nucleic Acids
Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of H2O2
CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model - Translational Research
Functional genomics and the future of iPSCs in disease modeling - ScienceDirect
CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa: Molecular Therapy
Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management - The Lancet Neurology
de
por adulto (o preço varia de acordo com o tamanho do grupo)